Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • UVXY vs GSK✓SelectedUSD · GSKUVXY vs GSK performance historyLatest closeAs of+22.46%11/20
Stock and ETF performance explorer

UVXY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-100.0%
GSK return
+149.7%
Excess return
-249.7%
Maximum drawdown
-100.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+22.5%-0.1%+22.6%+22.2%
7D+73.0%-5.3%+78.4%+57.2%
30D+85.3%-3.7%+89.0%+76.6%
3M+56.6%-7.3%+63.8%+37.2%
6M-8.7%-4.2%-4.5%-16.3%
YTD-13.4%+0.9%-14.2%-8.0%
1Y-52.6%+7.3%-59.9%-42.7%
3Y-88.7%+52.7%-141.4%-70.5%
5Y-99.2%+40.1%-139.3%-98.3%
10Y-100.0%+98.7%-198.7%-100.0%
All-100.0%+149.7%-249.7%-100.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling